2024-10-012025-09-302025-09-30false14936743MACARTHUR AGRICULTURE LTD2026-03-1268209falseiso4217:GBPxbrli:pure149367432024-09-30149367432025-09-30149367432024-10-012025-09-30149367432023-06-13149367432024-09-30149367432023-06-142024-09-3014936743bus:SmallEntities2024-10-012025-09-3014936743bus:AuditExempt-NoAccountantsReport2024-10-012025-09-3014936743bus:FullAccounts2024-10-012025-09-3014936743bus:PrivateLimitedCompanyLtd2024-10-012025-09-3014936743core:WithinOneYear2025-09-3014936743core:AfterOneYear2025-09-3014936743core:WithinOneYear2024-09-3014936743core:AfterOneYear2024-09-3014936743core:ShareCapital2025-09-3014936743core:SharePremium2025-09-3014936743core:RevaluationReserve2025-09-3014936743core:OtherReservesSubtotal2025-09-3014936743core:RetainedEarningsAccumulatedLosses2025-09-3014936743core:ShareCapital2024-09-3014936743core:SharePremium2024-09-3014936743core:RevaluationReserve2024-09-3014936743core:OtherReservesSubtotal2024-09-3014936743core:RetainedEarningsAccumulatedLosses2024-09-3014936743core:LandBuildings2025-09-3014936743core:PlantMachinery2025-09-3014936743core:Vehicles2025-09-3014936743core:FurnitureFittings2025-09-3014936743core:OfficeEquipment2025-09-3014936743core:NetGoodwill2025-09-3014936743core:IntangibleAssetsOtherThanGoodwill2025-09-3014936743core:ListedExchangeTraded2025-09-3014936743core:UnlistedNon-exchangeTraded2025-09-3014936743core:LandBuildings2024-09-3014936743core:PlantMachinery2024-09-3014936743core:Vehicles2024-09-3014936743core:FurnitureFittings2024-09-3014936743core:OfficeEquipment2024-09-3014936743core:NetGoodwill2024-09-3014936743core:IntangibleAssetsOtherThanGoodwill2024-09-3014936743core:ListedExchangeTraded2024-09-3014936743core:UnlistedNon-exchangeTraded2024-09-3014936743core:LandBuildings2024-10-012025-09-3014936743core:PlantMachinery2024-10-012025-09-3014936743core:Vehicles2024-10-012025-09-3014936743core:FurnitureFittings2024-10-012025-09-3014936743core:OfficeEquipment2024-10-012025-09-3014936743core:NetGoodwill2024-10-012025-09-3014936743core:IntangibleAssetsOtherThanGoodwill2024-10-012025-09-3014936743core:ListedExchangeTraded2024-10-012025-09-3014936743core:UnlistedNon-exchangeTraded2024-10-012025-09-3014936743core:MoreThanFiveYears2024-10-012025-09-3014936743core:Non-currentFinancialInstruments2025-09-3014936743core:Non-currentFinancialInstruments2024-09-3014936743dpl:CostSales2024-10-012025-09-3014936743dpl:DistributionCosts2024-10-012025-09-3014936743core:LandBuildings2024-10-012025-09-3014936743core:PlantMachinery2024-10-012025-09-3014936743core:Vehicles2024-10-012025-09-3014936743core:FurnitureFittings2024-10-012025-09-3014936743core:OfficeEquipment2024-10-012025-09-3014936743dpl:AdministrativeExpenses2024-10-012025-09-3014936743core:NetGoodwill2024-10-012025-09-3014936743core:IntangibleAssetsOtherThanGoodwill2024-10-012025-09-3014936743dpl:GroupUndertakings2024-10-012025-09-3014936743dpl:ParticipatingInterests2024-10-012025-09-3014936743dpl:GroupUndertakingscore:ListedExchangeTraded2024-10-012025-09-3014936743core:ListedExchangeTraded2024-10-012025-09-3014936743dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-10-012025-09-3014936743core:UnlistedNon-exchangeTraded2024-10-012025-09-3014936743dpl:CostSales2023-06-142024-09-3014936743dpl:DistributionCosts2023-06-142024-09-3014936743core:LandBuildings2023-06-142024-09-3014936743core:PlantMachinery2023-06-142024-09-3014936743core:Vehicles2023-06-142024-09-3014936743core:FurnitureFittings2023-06-142024-09-3014936743core:OfficeEquipment2023-06-142024-09-3014936743dpl:AdministrativeExpenses2023-06-142024-09-3014936743core:NetGoodwill2023-06-142024-09-3014936743core:IntangibleAssetsOtherThanGoodwill2023-06-142024-09-3014936743dpl:GroupUndertakings2023-06-142024-09-3014936743dpl:ParticipatingInterests2023-06-142024-09-3014936743dpl:GroupUndertakingscore:ListedExchangeTraded2023-06-142024-09-3014936743core:ListedExchangeTraded2023-06-142024-09-3014936743dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-06-142024-09-3014936743core:UnlistedNon-exchangeTraded2023-06-142024-09-3014936743core:NetGoodwill2025-09-3014936743core:IntangibleAssetsOtherThanGoodwill2025-09-3014936743core:LandBuildings2025-09-3014936743core:PlantMachinery2025-09-3014936743core:Vehicles2025-09-3014936743core:FurnitureFittings2025-09-3014936743core:OfficeEquipment2025-09-3014936743core:AfterOneYear2025-09-3014936743core:WithinOneYear2025-09-3014936743core:ListedExchangeTraded2025-09-3014936743core:UnlistedNon-exchangeTraded2025-09-3014936743core:ShareCapital2025-09-3014936743core:SharePremium2025-09-3014936743core:RevaluationReserve2025-09-3014936743core:OtherReservesSubtotal2025-09-3014936743core:RetainedEarningsAccumulatedLosses2025-09-3014936743core:NetGoodwill2024-09-3014936743core:IntangibleAssetsOtherThanGoodwill2024-09-3014936743core:LandBuildings2024-09-3014936743core:PlantMachinery2024-09-3014936743core:Vehicles2024-09-3014936743core:FurnitureFittings2024-09-3014936743core:OfficeEquipment2024-09-3014936743core:AfterOneYear2024-09-3014936743core:WithinOneYear2024-09-3014936743core:ListedExchangeTraded2024-09-3014936743core:UnlistedNon-exchangeTraded2024-09-3014936743core:ShareCapital2024-09-3014936743core:SharePremium2024-09-3014936743core:RevaluationReserve2024-09-3014936743core:OtherReservesSubtotal2024-09-3014936743core:RetainedEarningsAccumulatedLosses2024-09-3014936743core:NetGoodwill2023-06-1314936743core:IntangibleAssetsOtherThanGoodwill2023-06-1314936743core:LandBuildings2023-06-1314936743core:PlantMachinery2023-06-1314936743core:Vehicles2023-06-1314936743core:FurnitureFittings2023-06-1314936743core:OfficeEquipment2023-06-1314936743core:AfterOneYear2023-06-1314936743core:WithinOneYear2023-06-1314936743core:ListedExchangeTraded2023-06-1314936743core:UnlistedNon-exchangeTraded2023-06-1314936743core:ShareCapital2023-06-1314936743core:SharePremium2023-06-1314936743core:RevaluationReserve2023-06-1314936743core:OtherReservesSubtotal2023-06-1314936743core:RetainedEarningsAccumulatedLosses2023-06-1314936743core:AfterOneYear2024-10-012025-09-3014936743core:WithinOneYear2024-10-012025-09-3014936743core:Non-currentFinancialInstrumentscore:CostValuation2024-10-012025-09-3014936743core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-10-012025-09-3014936743core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-10-012025-09-3014936743core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-10-012025-09-3014936743core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-10-012025-09-3014936743core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-10-012025-09-3014936743core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-10-012025-09-3014936743core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-10-012025-09-3014936743core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-10-012025-09-3014936743core:Non-currentFinancialInstrumentscore:CostValuation2025-09-3014936743core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-09-3014936743core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-09-3014936743core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-09-3014936743core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-09-3014936743core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-09-3014936743core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-09-3014936743core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-09-3014936743core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-09-3014936743core:Non-currentFinancialInstrumentscore:CostValuation2024-09-3014936743core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-3014936743core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-3014936743core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-3014936743core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-3014936743core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-3014936743core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-3014936743core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-3014936743core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-3014936743bus:Director12024-10-012025-09-3014936743core:FurnitureFittingsToolsEquipment2024-09-3014936743core:FurnitureFittingsToolsEquipment2024-10-012025-09-3014936743core:FurnitureFittingsToolsEquipment2025-09-30

MACARTHUR AGRICULTURE LTD

Registered Number
14936743
(England and Wales)

Unaudited Financial Statements for the Year ended
30 September 2025

MACARTHUR AGRICULTURE LTD
Company Information
for the year from 1 October 2024 to 30 September 2025

Director

MACARTHUR, Andrew John Wyllie

Registered Address

James Watson House Montgomery Way
Rosehill
Carlisle
CA1 2UU

Registered Number

14936743 (England and Wales)
MACARTHUR AGRICULTURE LTD
Statement of Financial Position
30 September 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets340,18548,300
Investment property41,788,3641,788,364
1,828,5491,836,664
Current assets
Debtors5127,808130,705
Cash at bank and on hand18,145940
145,953131,645
Creditors amounts falling due within one year6(592,504)(575,383)
Net current assets (liabilities)(446,551)(443,738)
Total assets less current liabilities1,381,9981,392,926
Creditors amounts falling due after one year7(1,359,735)(1,381,050)
Provisions for liabilities8-(12,075)
Net assets22,263(199)
Capital and reserves
Called up share capital5050
Profit and loss account22,213(249)
Shareholders' funds22,263(199)
The financial statements were approved and authorised for issue by the Director on 12 March 2026, and are signed on its behalf by:
MACARTHUR, Andrew John Wyllie
Director
Registered Company No. 14936743
MACARTHUR AGRICULTURE LTD
Notes to the Financial Statements
for the year ended 30 September 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page. The principal activity of the company is that of leasing of commercial property and land, farming, agistment of sheep and dog kennels.
Basis of preparation
The financial statements have been prepared under the historical cost convention on a going concern basis unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.
Going concern
At the time of approving the financial statements, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus, the director continues to adopt the going concern basis of accounting in preparing the financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and/or the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. The assets residual values, useful lives and depreciation methods are reviewed and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposal are determined by comparing the proceeds with the carrying amount and are recognised in the Income Statement Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Fixtures and fittings5.5
Investment property
Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at the reporting end date. Changes in fair value are recognised in profit or loss.
Financial instruments
The company enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.
2.Average number of employees

20252024
Average number of employees during the year11
3.Tangible fixed assets

Fixtures & fittings

Total

££
Cost or valuation
At 01 October 2452,00652,006
Additions1,7941,794
At 30 September 2553,80053,800
Depreciation and impairment
At 01 October 243,7063,706
Charge for year9,9099,909
At 30 September 2513,61513,615
Net book value
At 30 September 2540,18540,185
At 30 September 2448,30048,300
4.Investment property
The 2025 valuations were made by the director on an open market value, for existing new basis.

£
Fair value at 01 October 241,788,364
At 30 September 251,788,364
5.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables-1,284
Other debtors127,808129,421
Total127,808130,705
6.Creditors: amounts due within one year

2025

2024

££
Bank borrowings and overdrafts21,315-
Taxation and social security7,5275,806
Other creditors561,038565,977
Accrued liabilities and deferred income2,6243,600
Total592,504575,383
Secured Loans Bank Loan amounts of £1,381,050.00 are secured over a legal mortgage over the land and property, cross guarantee with other related companies and a personal guarantee.
7.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts1,359,7351,381,050
Total1,359,7351,381,050
8.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)-12,075
Total-12,075
9.Related party transactions
During the period the company received rental income of £76,500 (2024 - £104,000) from Veterinary Immunogenics Limited, a company which the director has a common interest. During the period the company received rental income of £nil (2024 - £40,000) from Teviot Technologies USA Inc., a company which the director has a common interest. Included within other creditors is an amount of £97,643 (2024 - £97,643) due to Teviot Technologies USA Inc, a company in which the director has a common interest. This amount is unsecured, interest free and has no fixed terms of repayment. Included within debtors is an amount of £127,808 (2024 - £129,381) due from Veterinary Immunogenics Limited, a company in which the director has a common interest. This amount is unsecured, interest free and has no fixed terms of repayment.
10.Change in reporting period and impact on comparability
The comparative figures for the financial period ended 30 September 2024 are not directly comparable with those of the current financial period, as the prior period covered a long accounting period of 16 months, whereas the current financial period covers 12 months.